Request Sample Inquiry
Cell Therapy Market

Cell Therapy Market

Cell Therapy Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

187

Base Year:

2022

Date

Jan - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1236

Segments Covered
  • By Use-Type By Use-Type Clinical Use, Research Use
  • By Type By Type Autologous Therapies, Allogenic Therapies
  • By Region By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 11.21 Billion
Revenue 2030Revenue 2030: USD 27.95 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 12.10%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Cell Therapy Market - Segment Analysis
    1. Overview
    2. Global Cell Therapy Market, 2016 - 2028 (USD Million)
    3. Global Cell Therapy Market - by Use-Type
      1. By Clinical Use
      2. By Research Use
    4. Global Cell Therapy Market - by Type
      1. By Autologous Therapies
      2. By Allogenic Therapies
    5. Global Cell Therapy Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Cell Therapy Market - Segment Analysis
    1. Overview
    2. North America Cell Therapy Market, 2016 - 2028 (USD Million)
    3. North America Cell Therapy Market, by Use-Type
      1. By Clinical Use
      2. By Research Use
    4. North America Cell Therapy Market, by Type
      1. By Autologous Therapies
      2. By Allogenic Therapies
    5. North America Cell Therapy Market, by Country
      1. U.S.
        1. U.S. Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. U.S. Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      2. Canada
        1. Canada Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Canada Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      3. Mexico
        1. Mexico Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Mexico Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
  5. Europe Cell Therapy Market - Segment Analysis
    1. Overview
    2. Europe Cell Therapy Market, 2016 - 2028 (USD Million)
    3. Europe Cell Therapy Market, by Use-Type
      1. By Clinical Use
      2. By Research Use
    4. Europe Cell Therapy Market, by Type
      1. By Autologous Therapies
      2. By Allogenic Therapies
    5. Europe Cell Therapy Market, by Country
      1. Germany
        1. Germany Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Germany Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      2. UK
        1. UK Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. UK Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      3. France
        1. France Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. France Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      4. Spain
        1. Spain Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Spain Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      5. Italy
        1. Italy Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Italy Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      6. BENELUX
        1. BENELUX Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. BENELUX Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      7. Rest of Europe
        1. Rest Of Europe Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Rest Of Europe Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
  6. Asia Pacific Cell Therapy Market - Segment Analysis
    1. Overview
    2. Asia Pacific Cell Therapy Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Cell Therapy Market, by Use-Type
      1. By Clinical Use
      2. By Research Use
    4. Asia Pacific Cell Therapy Market, by Type
      1. By Autologous Therapies
      2. By Allogenic Therapies
    5. Asia Pacific Cell Therapy Market, by Country
      1. China
        1. China Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. China Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      2. Japan
        1. Japan Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Japan Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      3. India
        1. India Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. India Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      4. South Korea
        1. South Korea Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. South Korea Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      5. South East Asia
        1. South East Asia Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. South East Asia Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Rest of Asia Pacific Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
  7. Latin America Cell Therapy Market - Segment Analysis
    1. Overview
    2. Latin America Cell Therapy Market, 2016 - 2028 (USD Million)
    3. Latin America Cell Therapy Market, by Use-Type
      1. By Clinical Use
      2. By Research Use
    4. Latin America Cell Therapy Market, by Type
      1. By Autologous Therapies
      2. By Allogenic Therapies
    5. Latin America Cell Therapy Market, by Country
      1. Brazil
        1. Brazil Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Brazil Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      2. Argentina
        1. Argentina Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Argentina Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      3. Rest of Latin America
        1. Rest of Latin America Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Rest of Latin America Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
  8. Middle East & Africa Cell Therapy Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Cell Therapy Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Cell Therapy Market, by Use-Type
      1. By Clinical Use
      2. By Research Use
    4. Middle East & Africa Cell Therapy Market, by Type
      1. By Autologous Therapies
      2. By Allogenic Therapies
    5. Middle East & Africa Cell Therapy Market, by Country
      1. GCC Countries
        1. GCC Countries Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. GCC Countries Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      2. South Africa
        1. South Africa Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. South Africa Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Cell Therapy Market, By Use-Type
          1. By Clinical Use
          2. By Research Use
        2. Rest of Middle East & Africa Cell Therapy Market, By Type
          1. By Autologous Therapies
          2. By Allogenic Therapies
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. The major companies of the studied market are Pharmicell Co. Ltd
    2. Corestem Inc.
    3. Chiesi Farmaceutici SpA
    4. Tegoscience
    5. Anterogen Co. Ltd
    6. TiGenix (Takeda Pharmaceuticals)
    7. Stempeutics Research Pvt Ltd
    8. Nipro Corporation
    9. and Medipost Co. Ltd.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Cell Therapy valued at USD 11.21 Billion in 2022 and is expected to reach USD 27.95 Billion in 2030 growing at a CAGR of 12.10%.

  • The prominent players in the market are The major companies of the studied market are Pharmicell Co. Ltd, Corestem Inc., Chiesi Farmaceutici SpA, Tegoscience, Anterogen Co. Ltd, TiGenix (Takeda Pharmaceuticals), Stempeutics Research Pvt Ltd, Nipro Corporation, and Medipost Co. Ltd..

  • The market is project to grow at a CAGR of 12.10% between 2023 and 2030.

  • The driving factors of the Cell Therapy include

    • Rising Government Investments in Cell-Based Research

  • North America was the leading regional segment of the Cell Therapy in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy